Esperion Therapeutics, Inc. (ESPR) Stock News & Chart | StockAdder

(ESPR)

Esperion Therapeutics, Inc.

Stock chart and latest news for Esperion Therapeutics, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Esperion Therapeutics, Inc. News

PRO

Esperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?

Apr 9, 2026 Gotrade

Esperion Therapeutics, Inc. (ESPR) Stock Price Today & Analysis

Jan 13, 2026 Stock Titan

Vanguard (ESPR) Amendment: Reports zero ESPR common shares after internal realignment

Mar 26, 2026 Seeking Alpha

Esperion Therapeutics: Still An Attractive Risk/Reward Narrative As The Earnings Clock Ticks Toward Profitability

Nov 10, 2025 Investing.com

Esperion shares jump 8% on revenue beat, acquisition plans

Mar 10, 2026 Finviz

Esperion Therapeutics (ESPR) Earnings Expected to Grow: Should You Buy?

Feb 24, 2026 Quiver Quantitative

Esperion Therapeutics Announces Pricing of $75 Million Public Offering of Common Stock

Oct 8, 2025 Yahoo Finance

How The New Price Target Is Shaping The Story For Esperion Therapeutics (ESPR)

Jan 25, 2026 Stock Titan

Investors can watch Esperion at Needham's virtual healthcare event

Mar 31, 2026 Seeking Alpha

Esperion Therapeutics: Past The Turnaround, Waiting On Guidelines (NASDAQ:ESPR)

Feb 17, 2026 Yahoo Finance

Esperion Therapeutics Inc (ESPR) Strengthens Business Outlook Amid Strategic Agreements

Mar 4, 2026 Stock Titan

[Form 4] Esperion Therapeutics, Inc. Insider Trading Activity